US Bancorp’s VanEck Biotech ETF BBH Stock Holding History

US Bancorp’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-148	Closed	-$22.7K	–	4032
2025 Q2	$22.7K	Hold	148	–	–	﹤0.01%	3124
2025 Q1	$23.3K	Sell	148 -200	-57%	-$32.5K	﹤0.01%	3103
2024 Q4	$54.6K	Buy	348 +51	+17%	+$8.58K	﹤0.01%	2697
2024 Q3	$52.6K	Hold	297	–	–	﹤0.01%	2713
2024 Q2	$50K	Hold	297	–	–	﹤0.01%	2679
2024 Q1	$49.3K	Buy	297 +1	+0.3%	+$166	﹤0.01%	2708
2023 Q4	$49K	Hold	296	–	–	﹤0.01%	2682
2023 Q3	$46.1K	Buy	296 +146	+97%	+$23.3K	﹤0.01%	2486
2023 Q2	$23.4K	Hold	150	–	–	﹤0.01%	2897
2023 Q1	$24.3K	Hold	150	–	–	﹤0.01%	2888
2022 Q4	$24K	Hold	150	–	–	﹤0.01%	2902
2022 Q3	$21K	Hold	150	–	–	﹤0.01%	2994
2022 Q2	$22K	Hold	150	–	–	﹤0.01%	2992
2022 Q1	$24K	Hold	150	–	–	﹤0.01%	2971
2021 Q4	$28K	Hold	150	–	–	﹤0.01%	2930
2021 Q3	$30K	Hold	150	–	–	﹤0.01%	2906
2021 Q2	$30K	Hold	150	–	–	﹤0.01%	2919
2021 Q1	$26K	Hold	150	–	–	﹤0.01%	2898
2020 Q4	$25K	Hold	150	–	–	﹤0.01%	2808
2020 Q3	$24K	Hold	150	–	–	﹤0.01%	2721
2020 Q2	$24K	Hold	150	–	–	﹤0.01%	2730
2020 Q1	$19K	Hold	150	–	–	﹤0.01%	2765
2019 Q4	$21K	Hold	150	–	–	﹤0.01%	2861
2019 Q3	$18K	Hold	150	–	–	﹤0.01%	2878
2019 Q2	$19K	Hold	150	–	–	﹤0.01%	2887
2019 Q1	$19K	Hold	150	–	–	﹤0.01%	2869
2018 Q4	$17K	Hold	150	–	–	﹤0.01%	2867
2018 Q3	$20K	Hold	150	–	–	﹤0.01%	2920
2018 Q2	$18K	Hold	150	–	–	﹤0.01%	2966
2018 Q1	$18K	Hold	150	–	–	﹤0.01%	2971
2017 Q4	$19K	Hold	150	–	–	﹤0.01%	2941
2017 Q3	$20K	Hold	150	–	–	﹤0.01%	2895
2017 Q2	$19K	Hold	150	–	–	﹤0.01%	2892
2017 Q1	$18K	Hold	150	–	–	﹤0.01%	2866
2016 Q4	$16K	Sell	150 -27	-15%	-$2.94K	﹤0.01%	2902
2016 Q3	$20K	Hold	177	–	–	﹤0.01%	2807
2016 Q2	$18K	Sell	177 -30	-14%	-$3.2K	﹤0.01%	2836
2016 Q1	$21K	Sell	207 -16	-7%	-$1.67K	﹤0.01%	2733
2015 Q4	$28K	Buy	223 +73	+49%	+$8.94K	﹤0.01%	2684
2015 Q3	$17K	Hold	150	–	–	﹤0.01%	2912
2015 Q2	$20K	Hold	150	–	–	﹤0.01%	2933
2015 Q1	$19K	Hold	150	–	–	﹤0.01%	2954
2014 Q4	$17K	Hold	150	–	–	﹤0.01%	2940
2014 Q3	$16K	Hold	150	–	–	﹤0.01%	2915
2014 Q2	$14K	Hold	150	–	–	﹤0.01%	2966
2014 Q1	$14K	Hold	150	–	–	﹤0.01%	2947
2013 Q4	$13K	Hold	150	–	–	﹤0.01%	2908
2013 Q3	$12K	Hold	150	–	–	﹤0.01%	2829
2013 Q2	$10K	Buy	+150	New	+$10.4K	﹤0.01%	2851

Other funds holding BBH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

US Bancorp's BBH Position: Q3 2025 in Review

US Bancorp sold out of VanEck Biotech ETF (BBH) in Q3 2025, closing a stake of 148 shares — an estimated $22.7K sold.

US Bancorp first reported a position in BBH in Q2 2013 and held it in 49 quarters. The position peaked at $54.6K in Q4 2024. 106 funds tracked by Wall St. Rank hold BBH as of Q3 2025.

US Bancorp reported no remaining VanEck Biotech ETF position as of Q3 2025 after selling out during the quarter.
US Bancorp sold 148 VanEck Biotech ETF shares in Q3 2025, an estimated $22.7K.
US Bancorp first reported a position in VanEck Biotech ETF in Q2 2013 and held it in 49 quarters.
US Bancorp's VanEck Biotech ETF position peaked at $54.6K in Q4 2024.
106 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2025.

Based on US Bancorp's 13F filing for Q3 2025, filed 12 Nov 2025.